标题
Psychedelics action and schizophrenia
作者
关键词
-
出版物
Pharmacological Reports
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-10-30
DOI
10.1007/s43440-023-00546-5
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Gene Expression and Epigenetic Regulation in the Prefrontal Cortex of Schizophrenia
- (2023) Wiktor Bilecki et al. Genes
- Psychedelics promote plasticity by directly binding to BDNF receptor TrkB
- (2023) Rafael Moliner et al. NATURE NEUROSCIENCE
- The crosstalk between 5-HT2AR and mGluR2 in schizophrenia
- (2023) Somdatta Saha et al. NEUROPHARMACOLOGY
- Efficacy of 5-HT2A antagonists on negative symptoms in patients with schizophrenia: A meta-analysis
- (2023) B. Romeo et al. PSYCHIATRY RESEARCH
- Epigenetic Targets in Schizophrenia Development and Therapy
- (2023) Agnieszka Wawrzczak-Bargieła et al. Brain Sciences
- Structure-based discovery of nonhallucinogenic psychedelic analogs
- (2022) Dongmei Cao et al. SCIENCE
- Gs signaling pathway distinguishes hallucinogenic and nonhallucinogenic 5-HT2AR agonists induced head twitch response in mice
- (2022) Xiaoqian Liu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Integrating the neurodevelopmental and dopamine hypotheses of schizophrenia and the role of cortical excitation-inhibition balance.
- (2022) Oliver D. Howes et al. BIOLOGICAL PSYCHIATRY
- Effect of Psilocybin and Ketamine on Brain Neurotransmitters, Glutamate Receptors, DNA and Rat Behavior
- (2022) Adam Wojtas et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Could psychedelic drugs have a role in the treatment of schizophrenia? Rationale and strategy for safe implementation
- (2022) Gilly Wolf et al. MOLECULAR PSYCHIATRY
- Towards an understanding of psychedelic-induced neuroplasticity
- (2022) Abigail E. Calder et al. NEUROPSYCHOPHARMACOLOGY
- A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT2A Receptor Density in the Pig Brain
- (2021) Nakul Ravi Raval et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Low Doses of Psilocybin and Ketamine Enhance Motivation and Attention in Poor Performing Rats: Evidence for an Antidepressant Property
- (2021) Guy A. Higgins et al. Frontiers in Pharmacology
- In vivo evidence of lower synaptic vesicle density in schizophrenia
- (2021) Rajiv Radhakrishnan et al. MOLECULAR PSYCHIATRY
- Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers
- (2021) Joseph M. Rootman et al. Scientific Reports
- Prolonged epigenomic and synaptic plasticity alterations following single exposure to a psychedelic in mice
- (2021) Mario de la Fuente Revenga et al. Cell Reports
- Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin
- (2020) N. L. Mason et al. NEUROPSYCHOPHARMACOLOGY
- Lumateperone: A Novel Antipsychotic for Schizophrenia
- (2020) Jessica Greenwood et al. ANNALS OF PHARMACOTHERAPY
- Targeting Serotonin 5-HT2A Receptors to Better Treat Schizophrenia: Rationale and Current Approaches
- (2020) Joshua T. Kantrowitz CNS DRUGS
- Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects
- (2020) Friederike Holze et al. NEUROPSYCHOPHARMACOLOGY
- Hallucinations Under Psychedelics and in the Schizophrenia Spectrum: An Interdisciplinary and Multiscale Comparison
- (2020) Pantelis Leptourgos et al. SCHIZOPHRENIA BULLETIN
- Glutamate in schizophrenia: Neurodevelopmental perspectives and drug development
- (2020) Alice Egerton et al. SCHIZOPHRENIA RESEARCH
- A non-hallucinogenic psychedelic analogue with therapeutic potential
- (2020) Lindsay P. Cameron et al. NATURE
- Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms
- (2020) Antonio Inserra et al. PHARMACOLOGICAL REVIEWS
- Glutamate Hypothesis in Schizophrenia
- (2019) Yota Uno et al. PSYCHIATRY AND CLINICAL NEUROSCIENCES
- Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels
- (2019) Martin K. Madsen et al. NEUROPSYCHOPHARMACOLOGY
- LSD acutely impairs working memory, executive functions, and cognitive flexibility, but not risk-based decision-making
- (2019) Thomas Pokorny et al. PSYCHOLOGICAL MEDICINE
- Schizophrenia—An Overview
- (2019) Robert A. McCutcheon et al. JAMA Psychiatry
- Serotonin 5-HT2A receptor expression and functionality in postmortem frontal cortex of subjects with schizophrenia: Selective biased agonism via Gαi1-proteins
- (2019) Aintzane García-Bea et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Beyond the dopamine hypothesis of schizophrenia to three neural networks of psychosis: dopamine, serotonin, and glutamate
- (2018) Stephen M. Stahl CNS SPECTRUMS
- Synaptic loss in schizophrenia: a meta-analysis and systematic review of synaptic protein and mRNA measures
- (2018) Emanuele Felice Osimo et al. MOLECULAR PSYCHIATRY
- Meta regression: Relationship between antipsychotic receptor binding profiles and side-effects
- (2018) Baris Olten et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Progressive Reduction in Gray Matter in Patients with Schizophrenia Assessed with MR Imaging by Using Causal Network Analysis
- (2018) Yuchao Jiang et al. RADIOLOGY
- Psychedelics Promote Structural and Functional Neural Plasticity
- (2018) Calvin Ly et al. Cell Reports
- Current Concepts and Treatments of Schizophrenia
- (2018) Piotr Stępnicki et al. MOLECULES
- Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: effects on cognition
- (2018) Frederick S. Barrett et al. PSYCHOPHARMACOLOGY
- New Targets for Schizophrenia Treatment beyond the Dopamine Hypothesis
- (2017) Albert Yang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A Severity-Based Clinical Staging Model for the Psychosis Prodrome: Longitudinal Findings From the New York Recognition and Prevention Program
- (2017) Ricardo E. Carrión et al. SCHIZOPHRENIA BULLETIN
- Sensorimotor gating of the startle reflex: what we said 25 years ago, what has happened since then, and what comes next
- (2016) Neal R Swerdlow et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Allosteric signaling through an mGlu2 and 5-HT2Aheteromeric receptor complex and its potential contribution to schizophrenia
- (2016) José L. Moreno et al. Science Signaling
- Allosteric signaling through an mGlu2 and 5-HT2Aheteromeric receptor complex and its potential contribution to schizophrenia
- (2016) José L. Moreno et al. Science Signaling
- Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects
- (2015) Yasmin Schmid et al. BIOLOGICAL PSYCHIATRY
- Variations in 5-HT2A Influence Spatial Cognitive Abilities and Working Memory
- (2014) Pingyuan Gong et al. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
- Quantitative Phosphoproteomics Unravels Biased Phosphorylation of Serotonin 2A Receptor at Ser280by HallucinogenicversusNonhallucinogenic Agonists
- (2014) Samah Karaki et al. MOLECULAR & CELLULAR PROTEOMICS
- Chronic LSD alters gene expression profiles in the mPFC relevant to schizophrenia
- (2014) David A. Martin et al. NEUROPHARMACOLOGY
- Acute effects of ayahuasca on neuropsychological performance: differences in executive function between experienced and occasional users
- (2013) José Carlos Bouso et al. PSYCHOPHARMACOLOGY
- Dysregulated 5-HT2A receptor binding in postmortem frontal cortex of schizophrenic subjects
- (2012) Carolina Muguruza et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Identification of Three Residues Essential for 5-Hydroxytryptamine 2A-Metabotropic Glutamate 2 (5-HT2A·mGlu2) Receptor Heteromerization and Its Psychoactive Behavioral Function
- (2012) José L. Moreno et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Dendritic spine pathology in schizophrenia
- (2012) J.R. Glausier et al. NEUROSCIENCE
- Pimavanserin, a selective serotonin (5-HT)2A-inverse agonist, enhances the efficacy and safety of risperidone, 2mg/day, but does not enhance efficacy of haloperidol, 2mg/day: Comparison with reference dose risperidone, 6mg/day
- (2012) Herbert Y. Meltzer et al. SCHIZOPHRENIA RESEARCH
- 5-HT2Areceptor signalling through phospholipase D1 associated with its C-terminal tail
- (2011) Zoë Barclay et al. BIOCHEMICAL JOURNAL
- Decoding the Signaling of a GPCR Heteromeric Complex Reveals a Unifying Mechanism of Action of Antipsychotic Drugs
- (2011) Miguel Fribourg et al. CELL
- Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists
- (2011) José L. Moreno et al. NEUROSCIENCE LETTERS
- Decreased Efficiency of Task-Positive and Task-Negative Networks During Working Memory in Schizophrenia
- (2011) P. D. Metzak et al. SCHIZOPHRENIA BULLETIN
- Epigenetic dysregulation of HTR2A in the brain of patients with schizophrenia and bipolar disorder
- (2011) Hamid Mostafavi Abdolmaleky et al. SCHIZOPHRENIA RESEARCH
- Serotonin, But Not N-Methyltryptamines, Activates the Serotonin 2A Receptor Via a -Arrestin2/Src/Akt Signaling Complex In Vivo
- (2010) C. L. Schmid et al. JOURNAL OF NEUROSCIENCE
- Age-related cortical thinning in schizophrenia
- (2010) Manabu Kubota et al. SCHIZOPHRENIA RESEARCH
- Characteristics of the MATRICS Consensus Cognitive Battery in a 29-site antipsychotic schizophrenia clinical trial
- (2010) Richard S.E. Keefe et al. SCHIZOPHRENIA RESEARCH
- Agonist-Trafficking and Hallucinogens
- (2009) Javier Gonzalez-Maeso et al. CURRENT MEDICINAL CHEMISTRY
- Decreased density of serotonin 2A receptors in the superior temporal gyrus in schizophrenia-a postmortem study
- (2009) Kai Kang et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Molecular biology of 5-HT receptors
- (2008) Jason Hannon et al. BEHAVIOURAL BRAIN RESEARCH
- Sensorimotor Gating of Schizophrenia Patients Is Influenced by 5-HT2A Receptor Polymorphisms
- (2008) Boris B. Quednow et al. BIOLOGICAL PSYCHIATRY
- Serotonin Receptors
- (2008) David E. Nichols et al. CHEMICAL REVIEWS
- Cortical grey matter volume and sensorimotor gating in schizophrenia
- (2008) Veena Kumari et al. CORTEX
- Realistic expectations of prepulse inhibition in translational models for schizophrenia research
- (2008) Neal R. Swerdlow et al. PSYCHOPHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More